Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 47Lymphoma 18Myelodysplastic Syndromes 4Immunoglobulin Light-chain Amyloidosis 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Neoplasms, Plasma Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hematologic Neoplasms 2Breast Neoplasms 2Amyloidosis, Hereditary, Transthyretin-Related 2Amyloidosis 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Trigger Finger Disorder 1Thyroid Neoplasms 1Thrombocythemia, Essential 1Testicular Germ Cell Tumor 1Stomach Neoplasms 1Spinal Stenosis 1Smoldering Multiple Myeloma 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1

Interventions

Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Trigger Finger Disorder × Biopsy × Plasma cell × Clear all
NCT03886155 2021-12-22

CAST

The Cleveland Clinic

Completed
107 enrolled
Plasma cell

Amyloidosis, Hereditary, Transthyretin-Related, Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Trigger Finger Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡